{"entity":{"type":"insider","cik":"0001456864","url":"/insider/0001456864","json_url":"/insider/0001456864.json","name":"Gionco David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":26,"first":"2009-09-15","last":"2020-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Gionco David","source":"filing","n_filings":26,"first_seen":"2009-09-15","last_seen":"2020-04-03"}],"transactions":[{"id":2518869,"accession":"0001104659-20-043324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-043324","line_url":"/filing/0001104659-20-043324#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11524.0,"shares_display":"11,524","price_per_share":4.79,"price_display":"4.79","price_state":"stated","total_value":55199.96,"total_display":"55,199.96","total_whole":"55,200","shares_owned_after":282878.0,"shares_owned_after_display":"282,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-01","filed_date":"2020-04-03","scope":"insider"},{"id":2639244,"accession":"0001104659-20-037012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-037012","line_url":"/filing/0001104659-20-037012#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2849.0,"shares_display":"2,849","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":11054.12,"total_display":"11,054.12","total_whole":"11,054","shares_owned_after":316885.0,"shares_owned_after_display":"316,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-20","scope":"insider"},{"id":2105331,"accession":"0001104659-20-033488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-033488","line_url":"/filing/0001104659-20-033488#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8846.0,"shares_display":"8,846","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":43522.32,"total_display":"43,522.32","total_whole":"43,522","shares_owned_after":319734.0,"shares_owned_after_display":"319,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-13","scope":"insider"},{"id":2105328,"accession":"0001104659-20-033488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-033488","line_url":"/filing/0001104659-20-033488#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5011.0,"shares_display":"5,011","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":25455.88,"total_display":"25,455.88","total_whole":"25,456","shares_owned_after":328580.0,"shares_owned_after_display":"328,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-13","scope":"insider"},{"id":2251415,"accession":"0001104659-20-027399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-027399","line_url":"/filing/0001104659-20-027399#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9147.0,"shares_display":"9,147","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":58815.21,"total_display":"58,815.21","total_whole":"58,815","shares_owned_after":333591.0,"shares_owned_after_display":"333,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-28","scope":"insider"},{"id":2423821,"accession":"0001104659-20-000979","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-000979","line_url":"/filing/0001104659-20-000979#line-4","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":2064.56,"total_display":"2,064.56","total_whole":"2,065","shares_owned_after":235421.0,"shares_owned_after_display":"235,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2020-01-03","scope":"insider"},{"id":2423816,"accession":"0001104659-20-000979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-000979","line_url":"/filing/0001104659-20-000979#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1511.0,"shares_display":"1,511","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":16243.25,"total_display":"16,243.25","total_whole":"16,243","shares_owned_after":235618.0,"shares_owned_after_display":"235,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2020-01-03","scope":"insider"},{"id":2423812,"accession":"0001104659-20-000979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-000979","line_url":"/filing/0001104659-20-000979#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2388.0,"shares_display":"2,388","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":26196.36,"total_display":"26,196.36","total_whole":"26,196","shares_owned_after":237129.0,"shares_owned_after_display":"237,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-24","filed_date":"2020-01-03","scope":"insider"},{"id":2423805,"accession":"0001104659-20-000979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-000979","line_url":"/filing/0001104659-20-000979#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":421.0,"shares_display":"421","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":4454.18,"total_display":"4,454.18","total_whole":"4,454","shares_owned_after":239517.0,"shares_owned_after_display":"239,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2020-01-03","scope":"insider"},{"id":7912600,"accession":"0001104659-19-015343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-015343","line_url":"/filing/0001104659-19-015343#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":11.05,"price_display":"11.05","price_state":"stated","total_value":5856.5,"total_display":"5,856.50","total_whole":"5,857","shares_owned_after":224938.0,"shares_owned_after_display":"224,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-15","scope":"insider"},{"id":7912597,"accession":"0001104659-19-015343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-015343","line_url":"/filing/0001104659-19-015343#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13492.0,"shares_display":"13,492","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":149896.12,"total_display":"149,896.12","total_whole":"149,896","shares_owned_after":225468.0,"shares_owned_after_display":"225,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-15","scope":"insider"},{"id":8145707,"accession":"0001104659-19-013683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-013683","line_url":"/filing/0001104659-19-013683#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1381.0,"shares_display":"1,381","price_per_share":11.32,"price_display":"11.32","price_state":"stated","total_value":15632.92,"total_display":"15,632.92","total_whole":"15,633","shares_owned_after":238960.0,"shares_owned_after_display":"238,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-08","scope":"insider"},{"id":8115901,"accession":"0001104659-19-011258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-011258","line_url":"/filing/0001104659-19-011258#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8563.0,"shares_display":"8,563","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":103012.89,"total_display":"103,012.89","total_whole":"103,013","shares_owned_after":240341.0,"shares_owned_after_display":"240,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":6014250,"accession":"0001104659-18-017587","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-017587","line_url":"/filing/0001104659-18-017587","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9183.0,"shares_display":"9,183","price_per_share":17.379353152564523,"price_display":"17.38","price_state":"stated","total_value":159594.6,"total_display":"159,594.60","total_whole":"159,595","shares_owned_after":182209.0,"shares_owned_after_display":"182,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider","n_lines":2},{"id":6410241,"accession":"0001104659-18-016433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-016433","line_url":"/filing/0001104659-18-016433#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1413.0,"shares_display":"1,413","price_per_share":16.56,"price_display":"16.56","price_state":"stated","total_value":23399.28,"total_display":"23,399.28","total_whole":"23,399","shares_owned_after":152275.0,"shares_owned_after_display":"152,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-07","filed_date":"2018-03-09","scope":"insider"},{"id":6014229,"accession":"0001104659-18-013696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-013696","line_url":"/filing/0001104659-18-013696#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4584.0,"shares_display":"4,584","price_per_share":17.26,"price_display":"17.26","price_state":"stated","total_value":79119.84,"total_display":"79,119.84","total_whole":"79,120","shares_owned_after":153554.0,"shares_owned_after_display":"153,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-28","scope":"insider"},{"id":6014225,"accession":"0001104659-18-013696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-013696","line_url":"/filing/0001104659-18-013696#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":17.61,"price_display":"17.61","price_state":"stated","total_value":77484.0,"total_display":"77,484.00","total_whole":"77,484","shares_owned_after":158138.0,"shares_owned_after_display":"158,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-28","scope":"insider"},{"id":6092656,"accession":"0001104659-18-003104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-003104","line_url":"/filing/0001104659-18-003104#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250.0,"shares_display":"4,250","price_per_share":13.43,"price_display":"13.43","price_state":"stated","total_value":57077.5,"total_display":"57,077.50","total_whole":"57,078","shares_owned_after":162538.0,"shares_owned_after_display":"162,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-17","filed_date":"2018-01-19","scope":"insider"},{"id":5286252,"accession":"0001104659-17-015593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-015593","line_url":"/filing/0001104659-17-015593#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1116.0,"shares_display":"1,116","price_per_share":8.13,"price_display":"8.13","price_state":"stated","total_value":9073.08,"total_display":"9,073.08","total_whole":"9,073","shares_owned_after":95914.0,"shares_owned_after_display":"95,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":4737805,"accession":"0001104659-17-013192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-013192","line_url":"/filing/0001104659-17-013192#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2986.0,"shares_display":"2,986","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":20931.86,"total_display":"20,931.86","total_whole":"20,932","shares_owned_after":96906.0,"shares_owned_after_display":"96,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":4737801,"accession":"0001104659-17-013192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-013192","line_url":"/filing/0001104659-17-013192#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":6.97,"price_display":"6.97","price_state":"stated","total_value":24395.0,"total_display":"24,395.00","total_whole":"24,395","shares_owned_after":99892.0,"shares_owned_after_display":"99,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4485381,"accession":"0001104659-17-003866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-003866","line_url":"/filing/0001104659-17-003866#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3593.0,"shares_display":"3,593","price_per_share":11.46,"price_display":"11.46","price_state":"stated","total_value":41175.78,"total_display":"41,175.78","total_whole":"41,176","shares_owned_after":103392.0,"shares_owned_after_display":"103,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-19","filed_date":"2017-01-24","scope":"insider"},{"id":2421109,"accession":"0001104659-16-104298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-104298","line_url":"/filing/0001104659-16-104298#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1148.0,"shares_display":"1,148","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":6107.36,"total_display":"6,107.36","total_whole":"6,107","shares_owned_after":106467.0,"shares_owned_after_display":"106,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-10","scope":"insider"},{"id":2868373,"accession":"0001104659-16-090852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-090852","line_url":"/filing/0001104659-16-090852#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46.0,"shares_display":"46","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":215.74,"total_display":"215.74","total_whole":"216","shares_owned_after":35244.0,"shares_owned_after_display":"35,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-20","filed_date":"2016-01-21","scope":"insider"},{"id":2868368,"accession":"0001104659-16-090852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-090852","line_url":"/filing/0001104659-16-090852#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3171.0,"shares_display":"3,171","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":15284.22,"total_display":"15,284.22","total_whole":"15,284","shares_owned_after":35290.0,"shares_owned_after_display":"35,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-21","scope":"insider"},{"id":8708397,"accession":"0001104659-15-003755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-003755","line_url":"/filing/0001104659-15-003755#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3311.0,"shares_display":"3,311","price_per_share":14.22,"price_display":"14.22","price_state":"stated","total_value":47082.42,"total_display":"47,082.42","total_whole":"47,082","shares_owned_after":26689.0,"shares_owned_after_display":"26,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-21","scope":"insider"},{"id":4828182,"accession":"0001181431-13-054156","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-054156","line_url":"/filing/0001181431-13-054156","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47876.0,"shares_display":"47,876","price_per_share":0.08052834823293509,"price_display":"0.08","price_state":"stated","total_value":3855.3752,"total_display":"3,855.38","total_whole":"3,855","shares_owned_after":45764.0,"shares_owned_after_display":"45,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider","n_lines":5},{"id":4393861,"accession":"0001181431-13-015689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-015689","line_url":"/filing/0001181431-13-015689#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP & Chief Acct. Officer)","role_mark":"O","role_mark_label":"Officer (Group VP & Chief Acct. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP & Chief Acct. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1560.0,"shares_display":"1,560","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":1450.8,"total_display":"1,450.80","total_whole":"1,451","shares_owned_after":83640.0,"shares_owned_after_display":"83,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-08","scope":"insider"},{"id":8985158,"accession":"0001181431-11-005459","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-11-005459","line_url":"/filing/0001181431-11-005459#line-5","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP & CFO)","role_mark":"O","role_mark_label":"Officer (Group VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP & CFO","security_title":"Common Stock, $0.01 par value per","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2032.0,"shares_display":"2,032","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":20320.0,"total_display":"20,320.00","total_whole":"20,320","shares_owned_after":42735.0,"shares_owned_after_display":"42,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-24","filed_date":"2011-01-27","scope":"insider"},{"id":7410261,"accession":"0001181431-10-064156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-064156","line_url":"/filing/0001181431-10-064156#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP & CFO)","role_mark":"O","role_mark_label":"Officer (Group VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP & CFO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1536.0,"shares_display":"1,536","price_per_share":11.8702,"price_display":"11.87","price_state":"stated","total_value":18232.6272,"total_display":"18,232.63","total_whole":"18,233","shares_owned_after":44419.0,"shares_owned_after_display":"44,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-20","filed_date":"2010-12-30","scope":"insider"},{"id":7158093,"accession":"0001181431-10-009620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-009620","line_url":"/filing/0001181431-10-009620#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP & CFO)","role_mark":"O","role_mark_label":"Officer (Group VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP & CFO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1253.0,"shares_display":"1,253","price_per_share":13.8066,"price_display":"13.81","price_state":"stated","total_value":17299.6698,"total_display":"17,299.67","total_whole":"17,300","shares_owned_after":31155.0,"shares_owned_after_display":"31,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-16","filed_date":"2010-02-17","scope":"insider"},{"id":7262712,"accession":"0001181431-10-008438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-008438","line_url":"/filing/0001181431-10-008438#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP & CFO)","role_mark":"O","role_mark_label":"Officer (Group VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP & CFO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2037.0,"shares_display":"2,037","price_per_share":12.7652,"price_display":"12.77","price_state":"stated","total_value":26002.7124,"total_display":"26,002.71","total_whole":"26,003","shares_owned_after":32408.0,"shares_owned_after_display":"32,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-09","filed_date":"2010-02-11","scope":"insider"},{"id":5617136,"accession":"0001181431-09-058247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-058247","line_url":"/filing/0001181431-09-058247#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (VP, CFO)","role_mark":"O","role_mark_label":"Officer (VP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, CFO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1511.0,"shares_display":"1,511","price_per_share":12.946,"price_display":"12.95","price_state":"stated","total_value":19561.406,"total_display":"19,561.41","total_whole":"19,561","shares_owned_after":34445.0,"shares_owned_after_display":"34,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-21","filed_date":"2009-12-22","scope":"insider"},{"id":5775915,"accession":"0001181431-09-044026","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-09-044026","line_url":"/filing/0001181431-09-044026#line-6","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP, CFO)","role_mark":"O","role_mark_label":"Officer (Group VP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP, CFO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":15.95,"price_display":"15.95","price_state":"stated","total_value":119625.0,"total_display":"119,625.00","total_whole":"119,625","shares_owned_after":35895.0,"shares_owned_after_display":"35,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-15","scope":"insider"},{"id":5775913,"accession":"0001181431-09-044026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-09-044026","line_url":"/filing/0001181431-09-044026#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001456864","owner_name":"Gionco David","owner_display_name":"Gionco David","owner_url":"/insider/0001456864","role":"Officer (Group VP, CFO)","role_mark":"O","role_mark_label":"Officer (Group VP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group VP, CFO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10887.0,"shares_display":"10,887","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":167224.32,"total_display":"167,224.32","total_whole":"167,224","shares_owned_after":35895.0,"shares_owned_after_display":"35,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-14","filed_date":"2009-09-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001264587","name":"STEMLINE THERAPEUTICS INC","url":"/issuer/0001264587","role":"Officer (Chief Accounting Officer)","n_filings":18,"first_seen":"2015-01-21","last_seen":"2020-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Officer (Chief Accounting Officer)","n_filings":8,"first_seen":"2009-09-15","last_seen":"2013-10-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001456864","retrieved_at":"2026-08-22T17:52:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}